局部止痛藥市場：按產品類型、按活性成分、按類型、按應用、按患者細分、按分銷管道、按地區

Topical Pain Relief Market, By Product Type, By Active Ingredient, By Type, By Application, By Patient Demographics, By Distribution Channel, By Geography

出版日期: 2025年06月06日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

局部止痛藥市場規模預計在 2025 年達到 111 億美元，預計到 2032 年將達到 159.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 5.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	111億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	5.30%	2032年價值預測	159.3億美元

近年來，全球局部疼痛緩解市場經歷了顯著成長，這得益於慢性疼痛疾病患病率的上升、老年人口的成長以及人們對局部疼痛管理解決方案益處的認知的不斷提高。局部疼痛緩解產品透過將活性成分直接施用於患處來緩解局部疼痛，最大限度地減少全身暴露並降低與口服止痛藥相關的副作用風險。市場提供各種各樣的產品，包括乳膏、凝膠、噴霧劑、貼劑和軟膏，配製時含有各種活性成分，包括非類固醇消炎劑(NSAID)、薄荷醇、辣椒素和Lidocaine。隨著越來越多的消費者尋求安全有效的急性和慢性疼痛管理方法，局部止痛藥的需求預計將繼續成長。

市場動態

全球局部止痛藥市場受多種因素驅動，包括關節炎、背痛和運動傷害等慢性疼痛疾病的盛行率不斷上升，這些疾病需要長期的疼痛管理解決方案。全球老年人口的成長也促進了市場的成長，因為老年人更容易患上慢性疼痛。此外，人們對口服止痛藥副作用的認知不斷提高，導致消費者偏好轉向局部止痛藥，因為這類藥物能夠緩解局部疼痛，對全身的影響最小。然而，口服藥物和物理治療等替代性疼痛管理方案的出現，以及某些局部用藥產品對嚴重疼痛的療效有限，可能會抑制市場的成長。此外，對新型止痛外用藥核准的嚴格監管準則也可能對市場進入者構成挑戰。儘管存在這些市場限制，但對天然和有機止痛產品日益成長的需求、新型藥物輸送系統的市場開發以及包括電商平台在內的配銷通路的不斷拓展，正在為市場帶來巨大的成長機會。

本研究的主要特點

本報告對全球局部止痛藥市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在商機，並解釋了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出了全球局部止痛藥市場的主要企業簡介。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員將透過用於分析全球局部止痛藥市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 11.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 15.93 Bn

The global topical pain relief market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic pain conditions, rising geriatric population, and growing awareness about the benefits of topical pain management solutions. Topical pain relief products offer localized pain relief by delivering active ingredients directly to the affected area, minimizing systemic exposure and reducing the risk of adverse effects associated with oral pain medications. The market encompasses a wide range of products, including creams, gels, sprays, patches, and ointments, formulated with various active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs), menthol, capsaicin, and lidocaine. The demand for topical pain relief products is expected to continue growing as more consumers seek safe and effective options for managing acute and chronic pain conditions.

Market Dynamics

The global topical pain relief market is driven by several factors, including the rising prevalence of chronic pain conditions, such as arthritis, back pain, and sports injuries, which require long-term pain management solutions. The growing geriatric population worldwide is also contributing to the market growth, as older adults are more susceptible to chronic pain conditions. Moreover, the increasing awareness about the side effects associated with oral pain medications has led to a shift in consumer preference towards topical pain relief products, which offer localized pain relief with minimal systemic exposure. However, the market growth may be restrained by the availability of alternative pain management options, such as oral medications and physical therapy, as well as the limited efficacy of some topical products for severe pain conditions. Additionally, stringent regulatory guidelines for the approval of new topical pain relief products may pose challenges for market players. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for natural and organic pain relief products, the development of novel drug delivery systems, and the expansion of distribution channels, including e-commerce platforms.

Key Features of the Study

This report provides in-depth analysis of the global topical pain relief market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global topical pain relief market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline, Bayer AG, Novartis AG, Sanofi S.A., Merck & Co., Inc., Abbott Laboratories, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Reckitt Benckiser Group plc, Hisamitsu Pharmaceutical Co., Inc., and Mentholatum Company, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global topical pain relief market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical pain relief market.

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Gels
- Creams
- Ointments
- Patches
- Sprays
- Roll-ons
Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Counterirritants
- Anesthetics
- Salicylates
- Capsaicin
- Menthol
Type Insights (Revenue, USD Bn, 2020 - 2032)
- Prescription Pain Relief
- Over-the-Counter (OTC) Pain Relief
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Arthritis Pain
- Muscle and Joint Pain
- Back Pain
- Sports Injuries
- Neuropathic Pain
- Post-Surgical Pain
Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
- Adults
- Geriatrics
- Pediatrics
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Online Pharmacies
- Retail Pharmacies
- Hospitals Pharmacy
- Supermarkets/Hypermarkets
- Health and Wellness Stores
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Johnson & Johnson
- Pfizer Inc.
- GlaxoSmithKline
- Bayer AG
- Novartis AG
- Sanofi S.A.
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Astellas Pharma Inc.
- Mylan N.V.
- Reckitt Benckiser Group plc
- Hisamitsu Pharmaceutical Co., Inc.
- Mentholatum Company, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Topical Pain Relief Market, By Product Type
- Global Topical Pain Relief Market, By Active Ingredient
- Global Topical Pain Relief Market, By Type
- Global Topical Pain Relief Market, By Application
- Global Topical Pain Relief Market, By Patient Demographics
- Global Topical Pain Relief Market, By Distribution Channel
- Global Topical Pain Relief Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Topical Pain Relief Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Roll-ons
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Topical Pain Relief Market, By Active Ingredient, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Counterirritants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Salicylates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Capsaicin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Menthol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Topical Pain Relief Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Prescription Pain Relief
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Over-the-Counter (OTC) Pain Relief
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Topical Pain Relief Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Arthritis Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Muscle and Joint Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Back Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sports Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neuropathic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Post-Surgical Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Topical Pain Relief Market, By Patient Demographics, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Topical Pain Relief Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospitals Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Supermarkets/Hypermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Health and Wellness Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Topical Pain Relief Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Reckitt Benckiser Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hisamitsu Pharmaceutical Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mentholatum Company, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies